Next Article in Journal
Combined Strategies for Improving Aflatoxin B1 Degradation Ability and Yield of a Bacillus licheniformis CotA-Laccase
Previous Article in Journal
Mizoribine Promotes Molecular Chaperone HSP60/HSP10 Complex Formation
Previous Article in Special Issue
A Combination of Library Screening and Rational Mutagenesis Expands the Available Color Palette of the Smallest Fluorogen-Activating Protein Tag nanoFAST
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Analysis of Arc/Arg3.1 Oligomerization In Vitro and in Living Cells

by
Barbara Barylko
1,
Clinton A. Taylor 4th
1,
Jason Wang
2,
Per Niklas Hedde
3,4,
Yan Chen
5,
Kwang-Ho Hur
5,
Derk D. Binns
1,
Chad A. Brautigam
6,
George N. DeMartino
2,
Joachim D. Mueller
5,
David M. Jameson
3,* and
Joseph P. Albanesi
1,*
1
Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA
2
Department of Physiology, University of Texas Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA
3
Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, 651 Ilalo St., BSB 222, Honolulu, HI 96813, USA
4
Laboratory for Fluorescence Dynamics, University of California, Irvine, CA 92697, USA
5
School of Physics and Astronomy, University of Minnesota, Minneapolis, MN 55455, USA
6
Department of Biophysics, University of Texas Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390, USA
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(12), 6454; https://doi.org/10.3390/ijms25126454
Submission received: 24 May 2024 / Accepted: 6 June 2024 / Published: 12 June 2024

Abstract

:
Arc (also known as Arg3.1) is an activity-dependent immediate early gene product enriched in neuronal dendrites. Arc plays essential roles in long-term potentiation, long-term depression, and synaptic scaling. Although its mechanisms of action in these forms of synaptic plasticity are not completely well established, the activities of Arc include the remodeling of the actin cytoskeleton, the facilitation of AMPA receptor (AMPAR) endocytosis, and the regulation of the transcription of AMPAR subunits. In addition, Arc has sequence and structural similarity to retroviral Gag proteins and self-associates into virus-like particles that encapsulate mRNA and perhaps other cargo for intercellular transport. Each of these activities is likely to be influenced by Arc’s reversible self-association into multiple oligomeric species. Here, we used mass photometry to show that Arc exists predominantly as monomers, dimers, and trimers at approximately 20 nM concentration in vitro. Fluorescence fluctuation spectroscopy revealed that Arc is almost exclusively present as low-order (monomer to tetramer) oligomers in the cytoplasm of living cells, over a 200 nM to 5 μM concentration range. We also confirmed that an α-helical segment in the N-terminal domain contains essential determinants of Arc’s self-association.

1. Introduction

Arc (Activity-regulated cytoskeleton-associated protein) [1], also known as Arg 3.1 (Activity-regulated gene 3.1) [2], is an immediate early gene product that regulates multiple forms of synaptic plasticity, including long-term potentiation (LTP), long-term depression (LTD), and homeostatic plasticity [3,4,5,6]. Its role in these processes appears to be linked to its activities as a regulator of the actin cytoskeleton [3,5] and of AMAP receptor endocytosis [7]. At physiologic pH and ionic strength, Arc self-associates in vitro into multiple oligomeric species with diameters ranging from about 4 nm (monomer) to 20–35 nm (>30–40-m) [8,9,10,11]. The physiological significance of high-order Arc self-assembly has not been conclusively established, but its potential importance was highlighted by the demonstration that Arc forms virus-like particles that encapsulate mRNA for delivery into the extra-neuronal space [10,12]. Indeed, a segment comprising ~residues 207–370 in the C-terminal portion of Arc displays sequence [13] and structural [14] similarity to retroviral Gag domains. Arc dimerization and further oligomerization is driven by the second α-helix (~residues 78–140) within the N-terminal domain [15]. However, it may also be regulated by interactions with the C-terminal viral capsid-like domain, as the phosphorylation of serine 260 by Ca2+/calmodulin-dependent protein kinase II (CaMKII) suppresses high-order oligomerization [11].
At present, the in vivo mechanism of Arc self-assembly into virus-like structures is not understood. Arc interacts with nucleic acids in vitro and in cells [10,12]. Stripping Arc of its bound RNA prevents its assembly in vitro into ~32 nm particles that resemble viral capsids in cryo-electron micrographs [10], whereas the addition of mRNAs encoding Arc or GFP (green fluorescent protein) enhances the formation of these high-order oligomers [15]. Our previous fluorescence nanoimaging studies failed to reveal the presence of high-order oligomers in the cytosol of living cells [16]. However, these experiments were performed at average expression levels of less than 300 nM, which are considerably lower than the micromolar concentrations typically used to detect high-order Arc self-assembly in vitro. Moreover, Mergiya et al. [17] found by in situ chemical crosslinking that endogenous Arc is predominantly present as monomers and dimers in the rat brain, although low levels of trimers, tetramers, and higher-order oligomers could also be detected. Based on these observations, we have now investigated Arc oligomerization in vitro over a 1000-fold concentration range (~20 nM to ~20 μM) and performed single-point fluorescence fluctuation spectroscopy (FFS) measurements in live cells over a concentration range of ~200 nM to ~5 μM. Although we confirmed that ~30 nm diameter structures formed in vitro at micromolar concentrations, only low-order oligomers (up to tetramers) were evident in the cytosol of living cells. Using a combination of hydrodynamic and fluorescence nanoimaging approaches, we also confirmed results of Eriksen et al. [15], demonstrating the importance of an α-helix (which we term helix H2) in the N-terminal domain of Arc for its self-association in vitro and in cells.

2. Results

To date, high-order Arc oligomerization in solution has been characterized predominantly by dynamic light scattering (DLS) at Arc concentrations in the µM range [8,9,10,11]. To examine Arc self-association at lower concentrations, we used mass photometry, which has a sensitivity range of ~100 pM to ~100 nM. Mass photometry provides estimates of the molecular mass of proteins larger than ~30 kDa by quantification of the light scattered by individual particles upon binding to glass coverslips. We observed that bacterially expressed mouse Arc at ~20 nM concentration exists predominantly in a monomer/dimer/trimer equilibrium, with much lower levels of tetramers also evident (Figure 1A). Consistent with previously published values obtained by DLS and electron microscopy, the average hydrodynamic radius (RH) of Arc at this concentration was 17.0 ± 0.4 nm (Figure 1C). There was no evidence of low-order oligomers (monomers, dimers, etc.) in the DLS profiles. However, because the intensity of light scattered is proportional to the sixth power of the particle diameter, the contribution to the total light scattered by monomers and dimers is expected to be very small in the presence of ~30 nm diameter Arc particles.
To examine the behavior of Arc in live cells, we used fluorescence fluctuation spectroscopy (FFS), which provides estimates of the average stoichiometry from molecular brightness analysis and diffusion time determined from the autocorrelation function of fluorescently tagged proteins moving within the optical observation volume in the cell [18,19]. We first ascertained that the EGFP (enhanced GFP) tag did not interfere with low- or high-order Arc oligomerization. As with untagged Arc, mass photometry of EGFP-Arc (~20 nM final concentration) provided evidence of a monomer/dimer/trimer equilibrium (Figure 1B). Free EGFP, presumably cleaved from the fusion construct during preparation, was also evident in the profiles. We confirmed using size exclusion chromatography that the major contaminant in our Arc-EGFP samples is, indeed, free EGFP. DLS autocorrelation data revealed RH distributions that were dominated by an apparently single hydrodynamic species (polydispersity index of 0.081 ± 0.018) having an RH of 13.1 ± 0.4 nm (Figure 1D). Although the average RH of EGFP-Arc is somewhat smaller than that of untagged Arc, the values obtained by DLS for both species are in the range of those previously reported for high-order Arc oligomers/capsids.
We performed single-point FFS analyses over a broad range of concentrations (~200 nm to ~5 µM) in U2OS cells. Brightness analyses (Figure 2A,B) indicated that cytoplasmic particles containing EGFP-tagged Arc have an average stoichiometry of 1–3 Arc molecules per particle. Autocorrelation analysis (Figure 2C,D) revealed that the diffusion times (τD, which are inversely related to the diffusion coefficient, D) of EGFP-Arc and Arc-EGFP increase as a function of concentration. Soluble proteins with the molecular masses of EGFP-tagged monomeric, dimeric, and tetrameric Arc would be expected to have diffusion times of about 1.3, 1.6, and 2.0 ms, respectively. However, the measured diffusion times were scattered between ~2 and ~50 ms, confirming our previously reported observation that the diffusion process is dominated by Arc’s interaction with slowly moving partners, and not by the oligomeric state of Arc [16]. Moreover, the broad range of diffusion times suggests that these partners comprise a heterogeneous mixture of macromolecular complexes and/or transport vesicles. For comparison, τD values for β-actin mRNA [20] and small transport vesicles [21,22], as measured by FFS, are in the order of 50–100 msec. We note that the average residence times of EGFP-Arc were higher than those of Arc-EGFP, suggesting that the position of the fluorescent tag may influence the association of Arc with cytoplasmic binding partners without significantly affecting its oligomerization state.
As stated, Zhang et al. [11] identified serine 260 (S260) as a site of dynamic phosphorylation by CaMKII. They showed that a phosphomimetic mutation of this site (S260D) suppressed high-order Arc oligomerization at 30 °C in vitro, whereas the S260A mutation did not affect oligomerization. To address the possibility that the absence of high-order Arc oligomers in the cell cytosol is due to its phosphorylation on serine 260, we carried out FFS analysis of Arc-EGFP (S260D) and Arc-EGFP (S260A). As shown in Figure 3, these mutations had no significant effects on the stoichiometry (Figure 3A) or residence time (Figure 3B) of Arc.
An N-terminal α-helical domain is required for Arc dimerization in vitro and in cells. Eriksen et al. [15] have identified an α-helical segment, comprising residues 99–126, as being necessary for Arc dimerization and higher-order oligomerization. Consistent with these findings, we observed that a construct lacking residues 84–132 (which we term helix H2) behaves as a monomer in solution. Mass photometry analysis of ArcΔH2 at 20 nM indicated a molecular mass of ~39 kDa (Figure 4A), similar to its calculated molecular mass (including a GAMDP N-terminal extension) of 39,585 Da. Analytical ultracentrifugation (AUC) measurements carried out at ArcΔH2 concentrations ranging from 1.2–11.7 μM (Figure 4B) yielded a sedimentation coefficient (S) of 2.27 ± 0.01, a molecular weight of 35,638 ± 862, and a frictional ratio (f/f0) of 1.67 ± 0.03. Because globular proteins have frictional ratios in the range of ~1.15–1.25 [23], we conclude that ArcΔH2 is a highly asymmetric and/or flexible molecule.
We next monitored the spatial distribution of EGFP-tagged ArcΔH2 within the cell using the Number and Brightness (N&B) method [24] (Figure 5). The N&B approach differs from the molecular brightness method employed in Figure 2 and Figure 3 by providing information from each pixel and, hence, from all areas of the cell. We expressed ArcΔH2-EGFP, and EGFP-ArcΔH2 in NIH-3T3 cells, and representative brightness plots of single cells are shown in Figure 5A. The brightness ranges of monomers, dimers, trimers, and tetramers are indicated by green, orange, red, and purple boxes (calibrated with a solution of monomeric EGFP). Based on this color scheme, Figure 5B shows the brightness maps of representative cells, with their fluorescence intensity images shown in Figure 5C. We quantified the oligomerization state as a function of the intracellular protein concentration as shown in Figure 5D, each point representing the average of a single cell. Statistical analysis of the measured oligomerization state showed that ArcΔH2 is almost exclusively monomeric in both the cell cytoplasm and nucleus.
Finally, to ascertain that ArcΔH2 cannot dimerize with wild-type Arc (ArcWT), we measured Förster resonance energy transfer (FRET) in cells expressing ArcΔH2-EGFP or EGFP-ArcΔH2 together with ArcWT-mCherry. FRET can occur if an acceptor fluorophore, in our case mCherry, comes within a few nanometers of a donor, EGFP. Both the intensity and lifetime of the donor are reduced by energy transfer. However, because lifetime measurements are more reliable reporters of FRET in living cells, we measured FRET by reduction in the lifetime of EGFP. Using a similar approach, we had previously detected strong FRET signals in NIH-3T3 cells co-expressing ArcWT-EGFP and ArcWT-mCherry [16]. In contrast, no FRET was observed between EGFP-tagged ArcΔH2 and ArcWT-mCherry (Figure 6). The fluorescence lifetime of each pixel was calculated and displayed using phasor plots [25]. Figure 6A,C show that the center of mass of the lifetime distributions fall on the universal semicircle, indicating a single exponential lifetime decay, as expected for unquenched EGFP. In Figure 6B,D (bottom row of panels), these pixels are highlighted with a cyan color, showing their uniform distribution within the entire cell. Almost no quenched EGFP was detected, as demonstrated by the absence of pixels highlighted with a magenta color in the cells. The corresponding fluorescence intensity images for EGFP-ArcΔH2 are shown in Figure 6B,D (top row of panels). These results independently confirm that the H2 domain is critical for Arc dimerization in cells.

3. Discussion

Our mass photometry and DLS measurements confirmed that Arc self-associates in vitro into monomers, dimers, and trimers at ~20 nM concentration and to high-order oligomers (~30 nm diameter) at ~10 μM concentration. However, we failed to detect Arc species larger than tetramers in the cytosol of living cells by FFS, at expression levels ranging from ~0.2 to ~5.0 μM. It should be noted that our FFS approaches rely on the movement of fluorescent particles. Hence, only mobile molecules are monitored. The absence of high-order oligomers in the cytosol suggests that Arc assembles into virus-like particles on the plasma membrane or on the surface of slowly moving organelles, such as endosomes. This mechanism would not be surprising, as Gag binding to the plasma membrane (PM) is an essential step in the assembly of HIV-1 viral particles in cells [26]. In this case, the viral lattice grows by recruitment of Gag monomers and dimers from the cytosol, eventually inducing negative membrane curvature as a prelude to viral budding. Non-specific interactions between RNA and a highly basic region in the Gag N-terminal domain facilitates selective Gag binding to phosphatidylinositol (4,5)-bisphosphate on the PM. Interestingly, The N-terminal basic region of Arc also binds non-specifically to RNA [10,15]. Moreover, we have shown that Arc induces negative membrane curvature in giant unilamellar vesicles [27].
Recently, Eriksen and Bramham proposed an “oligomeric state hypothesis” to explain how Arc promotes such diverse neuronal activities as LTP, LTD, and intercellular communication [28]. They suggested that distinct Arc functions are driven by Arc in different oligomeric states. For example, dimers may regulate the actin cytoskeleton during LTP, whereas tetramers may promote AMPAR endocytosis during LTD. The role of high-order oligomerization (30–40 Arc subunits) is less clear. As stated, these 30–40-m may represent stages in the formation of virus-like particles. However, the reduction in synaptic depression caused by expression of the Arc (S260D) mutant, which can tetramerize but fails to form 32-m, suggests that high-order Arc oligomerization may also contribute to full expression of LTD [11]. As pointed out by Eriksen and Bramham [28], a 32-subunit “octamer of tetramers” would facilitate the putative scaffolding of endocytic proteins (e.g., dynamins and endophilins) on the clathrin-coated pit.
Our results raise two major questions and a challenge. The first question: why can Arc self-associate into high-order oligomers in vitro at μM concentrations, whereas only low-order oligomers are evident at similar concentrations in the cytosol of living cells? Arc is an interaction hub that binds to at least 30 partners [28,29]. Therefore, it is possible that Arc associates with molecules in the cytosol that suppress its high-order self-assembly. Indeed, our autocorrelation analyses indicate that Arc monomers and dimers are present in moving cytosolic complexes that are larger than expected for proteins with the monomeric molecular masses of Arc (~45 kDa). The second, related, question raised by our studies regards the identity of the molecules that associate with Arc in the cytosol and slow its migration in FFS experiments. Many of the validated Arc interactors are membrane-associated proteins and/or are preferentially expressed in neurons. However, several others, e.g., endophilin 2, dynamin 2, and CaMKII, can also be found in the cytosol of nearly all cells. We believe that dual-color FFS approaches in cells co-expressing EGFP-tagged Arc and mCherry-tagged candidate binding partners will be useful in addressing this question. Finally, a central challenge will be to directly test the assumption that Arc assembles into high-order oligomers on biological membranes. Again, FFS approaches, perhaps coupled with total internal reflection fluorescence (TIRF), should prove useful in tackling this difficult problem.

4. Materials and Methods

4.1. Materials

Resins: Ni2+-NTA resin (Roche, Indianapolis, IN, USA); Pierce Glutathione Agarose (ThermoFisher Scientific, Waltham, MA, USA); Q-Sepharose (Sigma-Aldrich, Burlington, MA, USA). His6-maltose-binding protein (MBP)-tagged Tobacco Etch Virus (TEV) protease (Elizabeth Goldsmith, UT Southwestern Medical Center). Mouse Arc cDNA, cloning reagents, and reagents for mutagenesis were from Thermo Scientific. Primers were from Invitrogen. pGST-parallel1 vector was a gift from Hong Zhang, UT Southwestern. Reagents for electrophoresis were from Bio-Rad (Hercules, CA, USA). HEPES, Tris, protease inhibitor cocktail (cOmplate CO-RO), lysozyme, glutaraldehyde, Triton X-100, and other reagents were from Sigma-Aldrich.

4.2. Cell Culture and Transfection

For brightness and autocorrelation analysis, U2OS cells (ATCC) were cultured in 10% fetal bovine serum (JR Scientific, Woodland, CA, USA) and DMEM and transfected 24 h before each measurement using GenJet In Vitro DNA Transfection Reagent (SignaGen Laboratories, Frederick, MD, USA). For Number and Brightness (N&B) and fluorescence lifetime imaging (FLIM) analysis, NIH-3T3 cells (ATCC) were plated on fibronectin-coated dishes, cultured in DMEM (supplemented with 10% FBS and 1% Pen-Strep), and transfected with Lipofectamine 3000 (ThermoFisher Scientific).

4.3. Constructs for Expression of Recombinant Wild-Type (WT) and Mutant Arc

To obtain GST-Arc with a TEV cleavage site (ENLYFQ) at the N terminus, mouse Arc cDNA was cloned into the pGST-parallel1 vector. This construct was also used as a template for making the ΔH2 deletion construct by PCR. To generate EGFP-tagged Arc for mammalian expression, GST-Arc was used as a template for subcloning Arc into vector pEGFP-N1 (to obtain Arc-EGFP) or pEGFP-C1 (to obtain EGFP-Arc). All DNA constructs were verified by sequencing. The His6-EGFP-Arc construct for bacterial expression had the following sequence: MSYY-(His6)-DYDIPTTENLYFQGAMDP-(EGFP)-SGLRSRA-(Arc). The resultant protein has a calculated mw of 76,368 and a theoretical isoelectric point of 5.54.

4.4. Protein Purification

Arc and Arc deletion/truncation mutants were expressed in E. coli Rosetta 2 cells and purified as previously described [9]. Cells were harvested after growing for 20 h at 16 °C. His6-Arc or GST-Arc was extracted from the bacterial pellet with solution A (20 mM HEPES, pH 8.0, 100 mM NaCl, 5 mM DTT, protease inhibitor cocktail, and 0.2 mM phenylmethylsulfonyl fluoride (PMSF)) and 0.05 mg/mL lysozyme. The extract was centrifuged at 100,000× g for 1 h and the supernatant was incubated either with Ni2+-NTA resin (for His6-Arc) or glutathione resin (for GST-Arc) for at least 4 h at 4 °C. Details of His6-Arc preparation were described previously [9]. Extracts containing GST-Arc were incubated with glutathione resin either directly or after precipitation of Arc with ammonium sulfate at 35% saturation. The resin was first washed with solution A, then with solution A containing 0.2% Triton X-100, and finally with solution A containing 2 M NaCl (without detergent). Washed resin was eluted either with glutathione to obtain GST-Arc or incubated with TEV protease to release Arc. Arc was dialyzed against solution B (20 mM HEPES, pH 7.5, 100 mM NaCl, 0.5 mM TCEP (reducing agent (tris(2-carboxyethyl)phosphine), and 0.2 mM PMSF. If further purification was necessary, samples were subjected to anion-exchange chromatography on Q-Sepharose. His6-tagged TEV was removed by incubation of Arc samples with Ni2+-NTA. Purified Arc was aliquoted and stored at −70 °C. To remove aggregates that formed during storage, proteins were centrifuged at 230,000× g for 15 min at 4 °C immediately before each experiment.

4.5. Analytical Ultracentrifugation (AUC)

Sedimentation velocity (SV) measurements were performed using a Beckman-Coulter Optima XL-I centrifuge. Protein samples in solution B were incubated overnight at 4 °C and introduced into the sample sectors of standard dual-sectored charcoal-filled Epon centerpieces that had been sandwiched between two sapphire windows in a cylindrical housing [29]. The reference sectors were filled with a matched buffer. The assembled centrifugation cells were inserted into an An50-Ti rotor and allowed to equilibrate at the experimental temperature (20 °C) for ~2.5 h. Centrifugation was performed at 50,000 rpm, and the time-dependent protein-concentration profiles were measured using absorbance optics tuned to 280 nm. The SV data were time-stamp-corrected [30] using REDATE (https://www.utsouthwestern.edu/research/core-facilities/mbr/software/, accessed on 5 June 2024) Corrected data were analyzed using the c(s) methodology in SEDFIT [31,32] at a resolution of 150, and maximum-entropy regularization with a confidence level of 0.683. SEDNTERP [33] was used to calculate partial-specific volumes, solution densities, and solution viscosities. Figures were rendered in GUSSI [34].

4.6. Mass Photometry

Oligomerization of Arc and EGFP-Arc at low concentrations was analyzed by mass photometry on a Refeyn TwoMP instrument (Refeyn, Ltd., Oxford, UK). Purified proteins in solution B were diluted to working concentrations of 200 nM in phosphate-buffered saline (PBS). Cover slips were washed with isopropanol and ultrapure water and fitted with a grid of silicon sample gaskets. Mass photometry optics were focused onto a 16.2 µL PBS droplet, and 1.8 µL of diluted sample was mixed into the droplet immediately prior to initiating a 60 s interferometric recording. This resulted in a final protein concentration of 20 nM during data collection. Data were imported into DiscoverMP (Refeyn) software (https://www.refeyn.com, accessed on 5 June 2024) and converted to ratiometric contrasts. A linear standard curve between mass and ratiometric contrast (R2 = 0.9996) was derived from BSA, thyroglobulin, and IgM standards. Automatic Gaussian curve fitting was performed in DiscoverMP software to identify peak centers and distributions.

4.7. Dynamic Light Scattering (DLS)

DLS experiments were carried out in a Dynapro Nanostar instrument (Wyatt Technologies, Goleta, CA, USA) at 25 °C in buffer containing solution B. Samples (5 μL at approximately 20 µM) were dispensed into a quartz cuvette and irradiated with visible light at 661 nm. Autocorrelation data were acquired by averaging ten autocorrelation functions that had been collected for 5 s each. Three technical replicates were acquired. Data were analyzed using Dynamics, used in the regularization mode to calculate hydrodynamic radius distributions. Figures were rendered in GUSSI [34].

4.8. Fluorescence Fluctuation Spectroscopy (FFS)

For brightness and autocorrelation analysis (Figure 2), U2OS cells were transfected 24 h before each measurement. The beam of a Ti:Sapphire laser (Spectra Physics, Mai Tai, Mountain View, CA, USA) was focused at an excitation wavelength of 1000 nm with a 63x C-Apochromat water immersion objective (Zeiss, Oberkochen, Germany) into the cytoplasm of the cells to create a small excitation volume. EGFP-labeled Arc diffusing through the observation volume produced fluctuations in the fluorescence intensity that were recorded (Correlator.com, Bridgewater, NJ, USA) with a frequency of 20 kHz for 60 s per measurement. FFS data were analyzed using the generalized Q-parameter algorithm [35] to determine the brightness, λ, of the sample. Separate U2OS cells were transfected with EGFP alone to determine the reference brightness, λEGFP, of the label by averaging the results obtained on 10 different cells. The normalized brightness, b, is given by the ratio of the sample to the reference brightness, b = λ/λEGFP. Brightness, b, is a measure of the average oligomeric state of the sample with b = 1 indicating a monomeric and b = 2 a dimeric EGFP-labeled protein [36]. Brightness was corrected for the finite thickness of the cytoplasm by using z-scan [37]. The volume, VPSF = 0.16 fl, and beam waist, w0 = 0.4 μm, of the two-photon point spread function were determined as previously described [37]. The molar concentration of EGFP-labeled Arc was directly calculated from the average fluorescence intensity, F, brightness, and PSF volume. In addition to brightness, the autocorrelation function (ACF) of the sample was calculated from the FFS data. The experimental ACF function of Arc was broadened compared to the expected ACF of a single diffusion species, indicating the presence of a heterogeneous mixture of diffusion times. To account for this broadening, we fit the data using an anomalous diffusion model [38] to determine the effective diffusion time, τD. We also computed τD used a smoothing and interpolation algorithm [39,40]. Both methods yielded identical results within experimental uncertainty. τD is related to the diffusion coefficient, D, according to τD = w02/4D.

4.9. Number and Brightness (N&B) Analysis

NIH-3T3 cells were imaged at room temperature 15–25 h after transfection. Per data set, 100 frames of 256 × 256 pixels were acquired with a pixel dwell time of 10 μs; sample pixel size was 165 nm. For calibration, a solution of monomeric EGFP (500 nM) was prepared in PBS buffer. The true molecular brightness of EGFP monomers was measured as b = 0.11. All instrument parameters were kept identical. Data were analyzed in SimFCS (Globals Software, Irvine, CA, USA) (https//www.lfd.uci.edu/globals/, accessed on 5 June 2024).

4.10. Förster Resonance Energy Transfer/Fluorescence Lifetime Imaging (FRET/FLIM)

NIH-3T3 cells were transfected with plasmids encoding ArcΔH2-EGFP or EGFP-ArcΔH2, either alone or together with Arc-mCherry. Cells were imaged for a maximum duration of 90 min at room temperature 15–25 h after transfection using a Zeiss LSM880 laser scanning microscope (Carl Zeiss Inc., White Plains, NY, USA). EGFP fluorescence was excited at 880 nm (two-photon excitation, 80 MHz) and detected at 510–560 nm with a 40×, NA 1.2 water immersion lens in nondescanned mode using a hybrid photomultiplier detector (HPM-100, Becker & Hickl, Berlin, Germany) coupled to a FLIMBox (ISS, Champaign, IL, USA). Before FLIM, the presence of both donor (EGFP) and acceptor (mCherry) was verified with 488 and 594 nm excitation. For each data set, 35 frames of 256 × 256 pixels were acquired with a pixel dwell time of 16 μs. Data were analyzed in SimFCS.

4.11. Other Methods

Protein concentration was determined using the modified Lowry method [41] according to Peterson [42] with BSA as a standard. SDS-PAGE was carried out according to Laemmli [43]. Gels were scanned using the LICOR Odyssey system.

Author Contributions

Conceptualization, B.B., D.M.J., and J.P.A.; methodology, P.N.H., C.A.B., J.D.M., and D.M.J. formal analysis, P.N.H., C.A.B., J.D.M., Y.C., J.W., and C.A.T.4th; investigation, B.B., C.A.T.4th, J.W., P.N.H., Y.C., K.-H.H., and D.D.B.; resources, B.B. and D.D.B.; writing—original draft preparation, J.P.A.; writing—review and editing, B.B., J.W., C.A.B., G.N.D., J.D.M., D.M.J., and J.P.A.; visualization, J.W., C.A.B., Y.C., and P.N.H.; supervision, J.D.M., G.N.D., C.A.B., D.M.J., and J.P.A.; project administration, B.B., D.M.J., and J.P.A.; funding acquisition, J.P.A., D.M.J., G.N.D., and J.D.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Institutes of Health grants MH119516 (D.M.J. and J.P.A.), GM129088 (G.N.D.), and AI177264 (J.D.M.).

Data Availability Statement

The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding authors.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Lyford, G.L.; Yamagata, K.; Kaufmann, W.E.; Barnes, C.A.; Sanders, L.K.; Copeland, N.G.; Gilbert, D.J.; Jenkins, N.A.; Lanahan, A.A.; Worley, P.F. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 1995, 14, 433–445. [Google Scholar] [CrossRef]
  2. Link, W.; Konietzko, U.; Kauselmann, G.; Krug, M.; Schwanke, B.; Frey, U.; Kuhl, D. Somatodendritic expression of an immediate early gene is regulated by synaptic activity. Proc. Natl. Acad. Sci. USA 1995, 92, 5734–5738. [Google Scholar] [CrossRef]
  3. Newpher, T.M.; Harris, S.; Pringle, J.; Hamilton, C.; Soderling, S. Regulation of spine structural plasticity by Arc/Arg3.1. Semin. Cell Dev. Biol. 2018, 77, 25–32. [Google Scholar] [CrossRef]
  4. Epstein, I.; Finkbeiner, S. The Arc of cognition: Signaling cascades regulating Arc and implications for cognitive function and disease. Semin. Cell Dev. Biol. 2018, 77, 63–72. [Google Scholar] [CrossRef]
  5. Zhang, H.; Bramham, C.R. Arc/Arg3.1 function in long-term synaptic plasticity: Emerging mechanisms and unresolved issues. Eur. J. Neurosci. 2021, 54, 6696–6712. [Google Scholar] [CrossRef]
  6. Chen, Y.; Wang, X.; Xiao, B.; Luo, Z.; Long, H. Mechanisms and functions of activity-regulated cytoskeleton-associated protein in synaptic plasticity. Mol. Neurobiol. 2023, 60, 5738–5754. [Google Scholar] [CrossRef]
  7. Wall, M.J.; Corrêa, S.A.L. The mechanistic link between Arc/Arg3.1 expression and AMPA receptor endocytosis. Semin. Cell Dev. Biol. 2018, 77, 17–24. [Google Scholar] [CrossRef]
  8. Myrum, C.; Baumann, A.; Bustad, H.J.; Flydal, M.I.; Mariaule, V.; Alvira, S.; Cuéllar, J.; Haavik, J.; Soulé, J.; Valpuesta, J.M.; et al. Arc is a flexible modular protein capable of reversible self-oligomerization. Biochem. J. 2015, 468, 145–158. [Google Scholar] [CrossRef]
  9. Byers, C.E.; Barylko, B.; Ross, J.A.; Southworth, D.R.; James, N.G.; Taylor, C.A., 4th; Wang, L.; Collins, K.A.; Estrada, A.; Waung, M.; et al. Enhancement of dynamin polymerization and GTPase activity by Arc/Arg3.1. Biochim. Biophys. Acta 2015, 1850, 1310–1318. [Google Scholar] [CrossRef]
  10. Pastuzyn, E.D.; Day, C.E.; Kearns, R.B.; Kyrke-Smith, M.; Taibi, A.V.; McCormick, J.; Yoder, N.; Belnap, D.M.; Erlendsson, S.; Morado, D.R.; et al. The neuronal gene Arc encodes a repurposed retrotransposon Gag protein that mediates intercellular RNA transfer. Cell 2018, 172, 275–288. [Google Scholar] [CrossRef]
  11. Zhang, W.; Chuang, Y.A.; Na, Y.; Ye, Z.; Yang, L.; Lin, R.; Zhou, J.; Wu, J.; Qiu, J.; Savonenko, A.; et al. Arc oligomerization is regulated by CaMKII phosphorylation of the GAG domain: An essential mechanism for plasticity and memory formation. Mol. Cell 2019, 75, 13–25. [Google Scholar] [CrossRef]
  12. Ashley, J.; Cordy, B.; Lucia, D.; Fradkin, L.G.; Budnik, V.; Thomson, T. Retrovirus-like Gag protein Arc1 binds RNA and traffics across synaptic boutons. Cell 2018, 172, 262–274. [Google Scholar] [CrossRef]
  13. Campillos, M.; Doerks, T.; Shah, P.K.; Bork, P. Computational characterization of multiple Gag-like human proteins. Trends Genet. 2006, 22, 585–589. [Google Scholar] [CrossRef]
  14. Zhang, W.; Wu, J.; Ward, M.D.; Yang, S.; Chuang, Y.A.; Xiao, M.; Li, R.; Leahy, D.J.; Worley, P.F. Structural basis of arc binding to synaptic proteins: Implications for cognitive disease. Neuron 2015, 86, 490–500. [Google Scholar] [CrossRef] [PubMed]
  15. Eriksen, M.S.; Nikolaienko, O.; Hallin, E.I.; Grødem, S.; Bustad, H.J.; Flydal, M.I.; Merski, I.; Hosokawa, T.; Lascu, D.; Akerkar, S.; et al. Arc self-association and formation of virus-like capsids are mediated by an N-terminal helical coil motif. FEBS J. 2021, 288, 2930–2955. [Google Scholar] [CrossRef]
  16. Hedde, P.N.; Barylko, B.; Binns, D.D.; Jameson, D.M.; Albanesi, J.P. Differential mobility and self-association of Arc/Arg3.1 in the cytoplasm and nucleus of living cells. ACS Chem. Neurosci. 2022, 13, 876–882. [Google Scholar] [CrossRef]
  17. Mergiya, T.F.; Gundersen, J.E.T.; Kanhema, T.; Brighter, G.; Ishizuka, Y.; Bramham, C.R. Detection of Arc/Arg3.1 oligomers in rat brain: Constitutive and synaptic activity-evoked dimer expression in vivo. Front. Mol. Neurosci. 2023, 16, 1142361. [Google Scholar] [CrossRef]
  18. Digman, M.A.; Gratton, E. Lessons in fluctuation correlation spectroscopy. Annu. Rev. Phys. Chem. 2011, 62, 645–668. [Google Scholar] [CrossRef] [PubMed]
  19. Macdonald, P.; Johnson, J.; Smith, E.; Chen, Y.; Mueller, J.D. Brightness analysis. Methods Enzymol. 2013, 518, 71–98. [Google Scholar] [PubMed]
  20. Wu, B.; Chao, J.A.; Singer, R.H. Fluorescence fluctuation spectroscopy enables quantitative imaging of single mRNAs in living cells. Biophys. J. 2012, 102, 2936–2944. [Google Scholar] [CrossRef]
  21. Li, J.; Barylko, B.; Johnson, J.; Mueller, J.D.; Albanesi, J.P.; Chen, Y. Molecular brightness analysis reveals phosphatidylinositol 4-kinase IIβ association with clathrin-coated vesicles in living cells. Biophys. J. 2012, 103, 1657–1665. [Google Scholar] [CrossRef] [PubMed]
  22. Perego, E.; Reshetniak, S.; Lorenz, C.; Hoffmann, C.; Milovanović, D.; Rizzoli, S.O.; Köster, S. A minimalist model to measure interactions between proteins and synaptic vesicles. Sci. Rep. 2020, 10, 21086. [Google Scholar] [CrossRef]
  23. Tanford, C. Physical Chemistry of Macromolecules; Wiley: New York, NY, USA, 1961. [Google Scholar]
  24. Digman, M.A.; Dalal, R.; Horwitz, A.F.; Gratton, E. Mapping the Number of Molecules and Brightness in the Laser Scanning Microscope. Biophys. J. 2008, 94, 2320–2332. [Google Scholar] [CrossRef]
  25. Malacrida, L.; Ranjit, S.; Jameson, D.M.; Gratton, E. The Phasor Plot: A Universal Circle to Advance Fluorescence Lifetime Analysis and Interpretation. Annu. Rev. Biophys. 2021, 50, 575–593. [Google Scholar] [CrossRef] [PubMed]
  26. Sumner, C.; Ono, A. Relationship between HIV-1 Gag multimerization and membrane binding. Viruses 2022, 14, 622. [Google Scholar] [CrossRef]
  27. Hedde, P.N.; Malacrida, L.; Barylko, B.; Binns, D.D.; Albanesi, J.P.; Jameson, D.M. Membrane remodeling by Arc/Arg3.1. Front. Mol. Biosci. 2021, 8, 630625. [Google Scholar] [CrossRef] [PubMed]
  28. Eriksen, M.S.; Bramham, C.R. Molecular physiology of Arc/Arg3.1: The oligomeric state hypothesis of synaptic plasticity. Acta Physiol. 2022, 236, e13886. [Google Scholar] [CrossRef]
  29. Nikolaienko, O.; Patil, S.; Eriksen, M.S.; Bramham, C.R. Arc protein: A flexible hub for synaptic plasticity and cognition. Semin. Cell Dev. Biol. 2018, 77, 33–42. [Google Scholar] [CrossRef]
  30. Schuck, P.; Zhao, H.; Brautigam, C.A.; Ghirlando, R. Basic Principles of Analytical Ultracentrifugation; CRC Press: Boca Raton, FL, USA, 2016. [Google Scholar]
  31. Zhao, H.; Ghirlando, R.; Piszczek, G.; Curth, U.; Brautigam, C.A.; Schuck, P. Recorded scan times can limit the accuracy of sedimentation coefficients in analytical ultracentrifugation. Anal. Biochem. 2013, 437, 104–108. [Google Scholar] [CrossRef]
  32. Schuck, P. Size distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 2000, 78, 1606–1619. [Google Scholar] [CrossRef]
  33. Schuck, P.; Perugini, M.A.; Gonzales, N.R.; Howlett, G.J.; Schubert, D. Size-distribution analysis of proteins by analytical ultracentrifugation: Strategies and application to model systems. Biophys. J. 2002, 82, 1096–1111. [Google Scholar] [CrossRef] [PubMed]
  34. Laue, T.M.; Shah, B.D.; Ridgeway, R.M.; Pelletier, S.L. Computer-aided interpretation of analytical sedimentation data for proteins. In Analytical Ultracentrifugation in Biochemistry and Polymer Science; Harding, S.E., Rowe, A.J., Horton, J.C., Eds.; The Royal Society of Chemistry: London, UK, 1992; pp. 90–125. [Google Scholar]
  35. Brautigam, C.A. Calculations and publication-quality illustrations for analytical ultracentrifugation data. Methods Enzymol. 2015, 562, 109–134. [Google Scholar] [PubMed]
  36. Sanchez-Andres, A.; Chen, Y.; Müller, J.D. Molecular brightness determined from a generalized form of Mandel’s Q-parameter. Biophys. J. 2005, 89, 3531–3547. [Google Scholar] [CrossRef] [PubMed]
  37. Chen, Y.; Wei, L.N.; Müller, J.D. Probing protein oligomerization in living cells with fluorescence fluctuation spectroscopy. Proc. Natl. Acad. Sci. USA 2003, 100, 15492–15497. [Google Scholar] [CrossRef] [PubMed]
  38. Macdonald, P.J.; Chen, Y.; Wang, X.; Chen, Y.; Mueller, J.D. Brightness analysis by Z-scan fluorescence fluctuation spectroscopy for the study of protein interactions within living cells. Biophys. J. 2010, 99, 979–988. [Google Scholar] [CrossRef] [PubMed]
  39. Wachsmuth, M.; Waldeck, W.; Langowski, J. Anomalous diffusion of fluorescent probes inside living cell nuclei investigated by spatially-resolved fluorescence correlation spectroscopy. J. Mol. Biol. 2000, 298, 677–689. [Google Scholar] [CrossRef] [PubMed]
  40. Li, J.; Chen, Y.; Li, M.; Carpenter, M.A.; McDougle, R.M.; Luengas, E.M.; Macdonald, P.J.; Harris, R.S.; Mueller, J.D. APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells. J. Mol. Biol. 2014, 426, 1296–1307. [Google Scholar] [CrossRef] [PubMed]
  41. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265–275. [Google Scholar] [CrossRef] [PubMed]
  42. Peterson, G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 1977, 83, 346–356. [Google Scholar]
  43. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680–685. [Google Scholar] [CrossRef]
Figure 1. Oligomerization of bacterially expressed and purified Arc and Arc-EGFP. (A,B) Mass photometry analyses of ~20 nM Arc and EGFP-Arc in PBS. The histograms (light blue) show the number of contrast events that are related to a given molecular mass. The solid line is a Gaussian fit to the dominant peak. (C,D) Dynamic light scattering analyses of ~10 μM Arc and Arc-EGFP in 20 mM HEPES, pH 7.5, 100 mM NaCl, 0.5 mM TCEP (tris(2-carboxyethyl)phosphine), and 0.2 mM PMSF (phenylmethylsulfonyl fluoride). Three replicate measurements are shown. It is not believed that the sharpness of replicate #2 in panel C has any physical significance. All measurements were performed at 25 °C.
Figure 1. Oligomerization of bacterially expressed and purified Arc and Arc-EGFP. (A,B) Mass photometry analyses of ~20 nM Arc and EGFP-Arc in PBS. The histograms (light blue) show the number of contrast events that are related to a given molecular mass. The solid line is a Gaussian fit to the dominant peak. (C,D) Dynamic light scattering analyses of ~10 μM Arc and Arc-EGFP in 20 mM HEPES, pH 7.5, 100 mM NaCl, 0.5 mM TCEP (tris(2-carboxyethyl)phosphine), and 0.2 mM PMSF (phenylmethylsulfonyl fluoride). Three replicate measurements are shown. It is not believed that the sharpness of replicate #2 in panel C has any physical significance. All measurements were performed at 25 °C.
Ijms 25 06454 g001
Figure 2. Concentration-dependent brightness and cytoplasmic diffusion of EGFP-Arc and Arc-EGFP expressed in U2OS cells. (A,B) Concentration-dependent brightness, b, of Arc with EGFP tag placed at the N-terminus (EGFP-Arc) or C-terminus (Arc-EGFP) at concentrations, c, up to 1.5 μM (A) or 5.5 μM (B). The value of b indicates the average stoichiometry of Arc in cytoplasmic complexes. (C,D) Cytoplasmic diffusion times, τD, of EGFP-Arc and Arc-EGFP for concentrations up to 1.5 μM (C) or 5.5 μM (D). Each data point represents average b and τD values from a single cell (27 cells expressing Arc-EGFP and 28 cells expressing EGFP-Arc). Concentrations of EGFP-tagged proteins in each cell were estimated as described in Materials and Methods.
Figure 2. Concentration-dependent brightness and cytoplasmic diffusion of EGFP-Arc and Arc-EGFP expressed in U2OS cells. (A,B) Concentration-dependent brightness, b, of Arc with EGFP tag placed at the N-terminus (EGFP-Arc) or C-terminus (Arc-EGFP) at concentrations, c, up to 1.5 μM (A) or 5.5 μM (B). The value of b indicates the average stoichiometry of Arc in cytoplasmic complexes. (C,D) Cytoplasmic diffusion times, τD, of EGFP-Arc and Arc-EGFP for concentrations up to 1.5 μM (C) or 5.5 μM (D). Each data point represents average b and τD values from a single cell (27 cells expressing Arc-EGFP and 28 cells expressing EGFP-Arc). Concentrations of EGFP-tagged proteins in each cell were estimated as described in Materials and Methods.
Ijms 25 06454 g002
Figure 3. Effect of Serine 260 mutations on brightness and cytoplasmic diffusion of Arc-EGFP. (A) Concentration-dependent brightness, b, of C-terminally EGFP-tagged wild-type Arc and the S260A and S260D mutants. (B) Cytoplasmic diffusion times, τD, of samples examined in panel A.
Figure 3. Effect of Serine 260 mutations on brightness and cytoplasmic diffusion of Arc-EGFP. (A) Concentration-dependent brightness, b, of C-terminally EGFP-tagged wild-type Arc and the S260A and S260D mutants. (B) Cytoplasmic diffusion times, τD, of samples examined in panel A.
Ijms 25 06454 g003
Figure 4. Analysis of ArcΔH2 in vitro. (A) Mass photometry analysis of purified, recombinant ArcΔH2 at 20 nM concentration. (B) Sedimentation velocity size distributions of three concentrations of ArcΔH2. The c(s) distributions have been normalized by the areas under the respective curves. Concentrations are shown in the inset.
Figure 4. Analysis of ArcΔH2 in vitro. (A) Mass photometry analysis of purified, recombinant ArcΔH2 at 20 nM concentration. (B) Sedimentation velocity size distributions of three concentrations of ArcΔH2. The c(s) distributions have been normalized by the areas under the respective curves. Concentrations are shown in the inset.
Ijms 25 06454 g004
Figure 5. Number and Brightness (N&B) analysis of ArcΔH2 in NIH-3T3 cells. (A) Representative brightness plots of cells expressing ArcΔH2-EGFP, and EGFP-ArcΔH2. Green, orange, red, and purple boxes indicate the brightness ranges of monomers, dimers, trimers, and tetramers. (B) Representative brightness map of the cell shown in panel C, color-coded according to the color scheme shown in panel (A). Green represents monomers; orange, dimers; red, trimers; and purple, higher-order oligomers. (C) Intensity images of the same cells. (D) Measured oligomerization state values (monomer = 1, dimer = 2, etc.) as a function of the intracellular protein concentration, each point representing the average of a single cell. Statistical analysis of the measured oligomerization state values using the Mann–Whitney non-parametric test (boxes: ±SE, whiskers: ±SD). * p < 0.05. Number of cells analyzed N = 14 (ArcΔH2-EGFP) and N = 9 (EGFP-ArcΔH2). Scale bar, 10 µm.
Figure 5. Number and Brightness (N&B) analysis of ArcΔH2 in NIH-3T3 cells. (A) Representative brightness plots of cells expressing ArcΔH2-EGFP, and EGFP-ArcΔH2. Green, orange, red, and purple boxes indicate the brightness ranges of monomers, dimers, trimers, and tetramers. (B) Representative brightness map of the cell shown in panel C, color-coded according to the color scheme shown in panel (A). Green represents monomers; orange, dimers; red, trimers; and purple, higher-order oligomers. (C) Intensity images of the same cells. (D) Measured oligomerization state values (monomer = 1, dimer = 2, etc.) as a function of the intracellular protein concentration, each point representing the average of a single cell. Statistical analysis of the measured oligomerization state values using the Mann–Whitney non-parametric test (boxes: ±SE, whiskers: ±SD). * p < 0.05. Number of cells analyzed N = 14 (ArcΔH2-EGFP) and N = 9 (EGFP-ArcΔH2). Scale bar, 10 µm.
Ijms 25 06454 g005
Figure 6. FRET/FLIM analysis in NIH-3T3 cells co-expressing EGFP-tagged ArcΔH2 and mCherry-tagged ArcWT. (A,C) Phasor plot pixel lifetime distribution of cells co-expressing donors: ArcΔH2-EGFP (panel A) or EGFP-ArcΔH2 (panel C) and acceptor: Arc-mCherry. Pixels corresponding to nonquenched EGFP (i.e., not displaying FRET) are enclosed in the cyan circle. Pixels corresponding to quenched EGFP (positive for FRET) are enclosed in the magenta circle. (B,D, top panels) Fluorescence intensity images of cells expressing ArcΔH2-EGFP (panel B) or EGFP-ArcΔH2 (panel D). (B,D, bottom panels) Pixel lifetime mapping of cells shown in the top panels. Pixels corresponding to non-quenched EGFP are in cyan; pixels corresponding to quenched EGFP are in magenta. Absence of magenta pixels in phasor plots and lifetime cursor maps demonstrates the overall absence of FRET, as confirmed upon examination of over 100 cells. Scale bars, 10 μm.
Figure 6. FRET/FLIM analysis in NIH-3T3 cells co-expressing EGFP-tagged ArcΔH2 and mCherry-tagged ArcWT. (A,C) Phasor plot pixel lifetime distribution of cells co-expressing donors: ArcΔH2-EGFP (panel A) or EGFP-ArcΔH2 (panel C) and acceptor: Arc-mCherry. Pixels corresponding to nonquenched EGFP (i.e., not displaying FRET) are enclosed in the cyan circle. Pixels corresponding to quenched EGFP (positive for FRET) are enclosed in the magenta circle. (B,D, top panels) Fluorescence intensity images of cells expressing ArcΔH2-EGFP (panel B) or EGFP-ArcΔH2 (panel D). (B,D, bottom panels) Pixel lifetime mapping of cells shown in the top panels. Pixels corresponding to non-quenched EGFP are in cyan; pixels corresponding to quenched EGFP are in magenta. Absence of magenta pixels in phasor plots and lifetime cursor maps demonstrates the overall absence of FRET, as confirmed upon examination of over 100 cells. Scale bars, 10 μm.
Ijms 25 06454 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Barylko, B.; Taylor, C.A., 4th; Wang, J.; Hedde, P.N.; Chen, Y.; Hur, K.-H.; Binns, D.D.; Brautigam, C.A.; DeMartino, G.N.; Mueller, J.D.; et al. Analysis of Arc/Arg3.1 Oligomerization In Vitro and in Living Cells. Int. J. Mol. Sci. 2024, 25, 6454. https://doi.org/10.3390/ijms25126454

AMA Style

Barylko B, Taylor CA 4th, Wang J, Hedde PN, Chen Y, Hur K-H, Binns DD, Brautigam CA, DeMartino GN, Mueller JD, et al. Analysis of Arc/Arg3.1 Oligomerization In Vitro and in Living Cells. International Journal of Molecular Sciences. 2024; 25(12):6454. https://doi.org/10.3390/ijms25126454

Chicago/Turabian Style

Barylko, Barbara, Clinton A. Taylor, 4th, Jason Wang, Per Niklas Hedde, Yan Chen, Kwang-Ho Hur, Derk D. Binns, Chad A. Brautigam, George N. DeMartino, Joachim D. Mueller, and et al. 2024. "Analysis of Arc/Arg3.1 Oligomerization In Vitro and in Living Cells" International Journal of Molecular Sciences 25, no. 12: 6454. https://doi.org/10.3390/ijms25126454

APA Style

Barylko, B., Taylor, C. A., 4th, Wang, J., Hedde, P. N., Chen, Y., Hur, K. -H., Binns, D. D., Brautigam, C. A., DeMartino, G. N., Mueller, J. D., Jameson, D. M., & Albanesi, J. P. (2024). Analysis of Arc/Arg3.1 Oligomerization In Vitro and in Living Cells. International Journal of Molecular Sciences, 25(12), 6454. https://doi.org/10.3390/ijms25126454

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop